The importance of lysosomes in CDK4/6 inhibitors resistance was also reported in breast cancer, where destabilizing lysosomes with chloroquine, seremesine, or azithromycin had a sensitizing effect in resistant triple-negative breast cancer cells [61]. The gene discussed is CDK4; the disease is breast carcinoma.